Table 2 Patient characteristics at admission
Characteristics | Group 1 2019 (137 Pts) n (%) | Group 2 2020 (109 Pts) n (%) | p-value |
|---|---|---|---|
Age years, median (q1–q3) | 53 (33–70) | 48 (32–70) | 0.41 |
Gender, n (%) | |||
Female | 42 (30.7) | 40 (36.7) | 0.32 |
Male | 95 (69.3) | 69 (63.3) | |
NRS median (q1–q3) | |||
≤3, n (%) | 50 (37.3) | 40 (36.7) | 0.98 |
4–6, n (%) | 34 (25.4) | 29 (26.6) | |
≥7, n (%) | 50 (37.3) | 40 (36.7) | |
NEWS at admission, median (q1-q3) | |||
0–4, n (%) | 101 (80.8) | 86 (78.90) | 0.39 |
5–6, n (%) | 10 (8.0) | 14 (12.8) | |
≥7, n (%) | 14 (11.2) | 9 (8.3) | |
CCI, median (q1-q3) | 2 (0–5) | 1 (0–5) | 0.99 |
Declared delayed access > 48 h, n (%) | 0 (0.0) | 16 (15.5) | < 0.01 |
Sepsis criteria, n (%) | 42 (31.3) | 31 (28.7) | 0.66 |
ASA score, median (q1-q3) | 2 (1–3) | 2 (1–3) | 0.35 |
COVID-19 molecular swab test results, n (%) | |||
Negative | n.a. | 81 (74.3) | |
Positive | n.a. | 5 (4.6) | |
Not available | n.a. | 23 (21.1) |